Increased responsiveness of human pulmonary arteries in patients with positive bronchodilator response

British Journal of Pharmacology

Volumn 119, Issue 7, 1996, Pages 1337-1340

  Cases, Enrique ^b   Vila, José M ^b   Medina, Pascual ^b   Aldasoro, Martín ^b   Segarra, Gloria ^b   Lluch, Salvador ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Acetylcholine; Bronchodilator test; Endothelium; Human pulmonary artery; Noradrenaline

Indexed keywords

ACETYLCHOLINE; ARGININE METHYL ESTER; ENDOTHELIN 1; NITROPRUSSIDE SODIUM; NORADRENALIN;

ADULT; AGED; ARTERY CONSTRICTION; ARTERY MUSCLE; ARTICLE; BRONCHODILATATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MALE; PRIORITY JOURNAL; PULMONARY ARTERY;

EID: 0029826578     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16043.x     Document Type: Article

References (15)

1. ADNOT, S., RAFFESTIN, B., EDDAHIBI, S., BRAQUET, P. & CHABRIER, P. (1991). Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest., 87, 155-162.
2. AMERICAN THORACIC SOCIETY. (1991). Lung function testing: Selection of reference values and interpretative strategies. Am. Rev. Respir. Dis., 144, 1202-1218.
3. BOUSHEY, H.A., HOLTZMAN, M.J., SHELLER, J.R. & NADEL, J.A. (1980). Bronchial hyperreactivity. Am. Rev. Respir. Dis., 121, 389-413.
4. BRAND, P.L.P., QUANJER, P.H., POSTMA, D.S., KERSTJENS, H.A.M., SLUITER, H.J. & KOËTER, G.H. (1990). A comparison of different ways to express bronchodilator response. Am. Rev. Respir. Dis., 141, A20.
5. DALES, R.E., SPITZER, W.O., TOUSIGNANT, P., SCHECHTER, M. & SUISSA, S. (1988). Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. Am. Rev. Respir. Dis., 138, 317-320.
6. DINH-XUAN, A.T., HIGENBOTTAM, T.W., CLELLAND, C.A., PEPKEZABA, J., CREMONA, G., BUTT, Y., LARGE, S.R., WELLS, F.C. & WALLWORK, J. (1991). Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N. Engl. M. Med., 324, 1539-1547.
7. EISER, N.M., KERREBIJN, K.F. & QUANJER, P.H. (1983). Guidelines for standardization of bronchial challenges with (nonspecific) bronchoconstricting agents. Bull. Eur. Physiopathol. Respir., 19, 495-514.
8. GROSS, N.J. (1986). COPD: a disease of reversible airflow obstruction. Am. Rev. Respir. Dis., 133, 725-726.
9. IGNARRO, L.J., LIPPTON, H.L., EDWARDS, J.C., BARICOS, W.H., HYMAN, A.L., KADOWITZ, P.J. & GRUETTER, C.A. (1981). Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther., 218, 739-749.
10. MARTÍNEZ, C., CASES, E., VILA, J.M., ALDASORO, M., MEDINA, P., MARCO, V. & LLUCH, S. (1995). Influence of endothelial nitric oxide on neurogenic contraction of human pulmonary arteries. Eur. Respir. J, 8, 1328-1332.
11. MCKAY, K.O., BLACK, J.L. & ARMOUR, C.L. (1991). The mechanism of action of endothelin in human lung. Br. J. Pharmacol., 102, 422-428.
12. MESLIER, N., RACINEUX, J., SIX, P. & LOCKHART, A. (1989). Diagnostic value of reversibility of chronic airway obstruction to separate asthma from chronic bronchitis: A statistical approach. Eur. Respir. J., 2, 497-505.
13. MURAD, F. (1986). Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest., 78, 1-5.
14. REES, D.D., PALMER, R.M.J., HODSON, H.F. & MONCADA, S. (1989). A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol., 96, 418-424.
15. WARREN, J.B., MALTBY, N.H., MACCORMACK, D. & BARNES, P.J. (1989). Pulmonary endothelium-derived relaxing factor is impaired in hypoxia. Clin. Sci., 77, 671-676.